At the 8th Future Medical Ecology Exhibition (VBEF) held at the Beijing Beiren Yichuang International Convention and Exhibition Center, Beijing Polyseq Biotechnology Co., Ltd. ("Polyseq Biotechnology") won multiple honors and three awards for its outstanding products and high-quality services.
This is not only a high recognition of the strong technological strength of Polyseq Biotechnology, but also a recognition of its continuous innovation and contribution in the medical and health industry. As an annual medical and health potential enterprise, Polyseq Biotechnology not only possesses strong technological strength and innovation capabilities, but also has keen market insight and forward-looking strategic planning. Looking ahead to the future, Polyseq Biotechnology will steadfastly delve into the field of healthcare, contributing more to the global healthcare industry with more outstanding products and services.
Co founder of Polyseq Biotechnology CEO， Dr. Wang Daqian gave a forum report titled "Leading Nanopore Sequencing Solution Provider in China", which pointed out the rapid growth of the global gene sequencer and consumables market, as well as China's market potential in this field. Nanopore sequencing technology plays an important role in RNA research, especially in the study of the association between non coding RNA and diseases. As the only technology that can directly sequence RNA, nanopore sequencing will play a key role. As a company focusing on nanopore sequencing technology, its technical achievements are derived from the transformation of scientific and technological achievements of the Institute of Biophysics, Chinese Academy of Sciences. The sequencing platform of Polyseq Biotechnology can provide one-stop solutions, which is fast, accurate, and long read, and is suitable for a variety of scientific research and clinical application scenarios.
Report on the Forum of Dr. Wang Daqian, Co founder and CEO of Polyseq Biotechnology
PolyseqOne, the first medium throughput portable nanopore sequencing system, was showcased by Polyseq Biotechnology at the conference center stage ™， It is the latest generation of gene sequencing system developed by combining nucleic acid chemistry, integrated circuit chips, software engineering, deep learning algorithms and other interdisciplinary technologies based on its independently developed new nanopore protein. This device is compact, portable, easy to operate, weighs only 1.5kg, and has 2560 sequencing units per chip. With a sequencing time of 48 hours, it can achieve a designed sequencing throughput of 15-20 Gb, providing a comprehensive solution for DNA/RNA sequencing. Polyseq Biotechnology is committed to providing strong support for the global healthcare industry through advanced science and technology and efficient service systems, helping more people enjoy higher quality medical services.
